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ABSTRACT 
 
Background: The aim of this study is to evaluate the efficacy, safety profile and the 
complications associated with mandibular distraction osteogenesis (MDO) performed in infants 
< 4kg with Robin sequence (RS). 
 
Methods: A 11-year retrospective review of all infants (< 6 months) with MDO treated RS was 
performed. Patients < 4 kg (experimental) and ≥ 4 kg (control) who underwent MDO were 
compared. Demographics, medical comorbidities, improvement in apnea/hypopnea index (AHI), 
need for tracheostomy, repeat distraction, and complications were evaluated.  
 
Results: One hundred twenty-one patients underwent MDO. 81 patients were < 4 kg while 40 
were ≥ 4 kg. The mean follow up was 2.8 years in patients < 4 kg and 3.0 years in the control 
group. Mean age and weight at time of distraction were 23 days old / 3.1 kg and 2.7 years / 11 
kg; respectively.  There was no significant difference in success of MDO to treat airway 
obstruction in the < 4 kg group versus the control group (92.6% vs. 88.9%; p = 0.49). The most 
common complication in each group was surgical site infection (9.9% and 20.0%; p = 0.15).  
Overall complication rates were similar between the two groups (17.3% vs. 25.0%; p = 0.34). 
The rates of repeat distraction were similar between the two groups (6.3% and 13.5%; p = 0.28).   
 
Conclusion: MDO is a safe and effective treatment modality for infants < 4 kg with severe 
airway obstruction. The efficacy, safety, and complication profiles are not significantly different 
from larger patients. 
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INTRODUCTION 
 
Mandibular distraction osteogenesis (MDO) is a standard technique in the 
armamentarium of the craniofacial surgeon treating bony deficiencies of the lower jaw. The 
surgical treatment of Robin sequence (RS), in particular, was revolutionized by the introduction 
of the distraction technique which restores airflow behind the tongue-base by direct, anterior 
translation of the mandible. After popularization by McCarthy,1 MDO was successfully applied 
to children with RS to relieve affected patients from tracheostomy.2-4 After these initial reports, 
MDO was applied to progressively younger patients including infants with severe airway 
obstruction associated with RS who would otherwise require tracheostomy.5-8 In many 
craniofacial centers, MDO is now the first line surgical intervention to treat severe RS in which 
conservative measures have been unsuccessful.  
The timing of intervention of MDO in newborns with RS can be a complex decision. 
Robin sequence is characterized by a heterogenous population9 defined by mandibular 
hypoplasia, glossoptosis and airway obstruction.10 Cleft palate has been erroneously included in 
the definition of RS despite Robin’s original description of the triad. Affected patients can have 
other medical diagnoses including syndromic/genetic abnormalities or additional anomalies of 
the respiratory, central nervous or circulatory systems. In addition, newborns with severe 
respiratory obstruction can present immediately after birth. In this subset of patients with the 
most severe presentation of airway obstruction, the timing of surgery may be delayed due to 
concerns for increased complications associated surgical intervention performed in the very 
small (< 4kg) or in the first days of life.   
Although infant distraction has been demonstrated to be safe3,11-17 and effective3,6,8,12,13,15-
17
 surgical outcomes in the newborn patient population have not been specifically reported. The 
purpose of this study is to report the surgical outcomes of MDO performed on infants who were 
less than 4kg at the time of their surgery. The goal of this analysis is to guide indications for 
MDO in neonates during the first days of life who are affected by severe airway obstruction. 
 
METHODS  
 
Patient Population 
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This study was approved by the Indiana University Institutional Review Board. An 11-
year retrospective review of all infants with RS treated with mandibular distraction, at a tertiary 
referral children’s hospital from January 2004 to March 2015, was performed. Patients < 6 
months of age and weighing < 4 kg at the time of distraction were included.  A control group of 
all Robin sequence patients ≥ 4 kg undergoing mandibular distraction during the same time 
period was used for comparison.   
 
Outcomes 
Patients’ demographics were recorded as well as associated medical comorbidities such 
as low birth weight, prematurity, intrauterine growth restriction, syndromic diagnosis, cardiac, 
respiratory or gastroinstestinal (gastroesophageal reflux (GER), history of Nissen fundoplication 
or gastrostomy tube) comorbidities. Other variables included improvement in apnea/hypopnea 
index (AHI), need for tracheostomy, repeat distraction, and complications. Complications were 
categorized as major, moderate, or minor, as defined by Davidson et al.18 Major complications 
were those that failed to improve or could not be improved with invasive therapy (i.e. tooth 
injury, fibrous nonunion, and device failure).  Moderate complications were those that could be 
revsolved by invasive therapy (i.e. premature ossification, device breakage/dislodgement, 
improper vector, and abscess).  Minor complications were self-limited or would improve without 
invasive therapy (i.e. pin-site infection, hypertrophic scarring, neurapraxia, hematoma).   
 
 
Treatment Protocol 
 A multidisciplinary team including plastic surgery, neonatology, genetics, pulmonology, 
developmental pediatrics, otolaryngology and nursing was involved in the care. Indication for 
MDO have been previously described.8,19 Briefly, patients were initially treated with prone 
positioning, supplemental oxygen, or non-invasive positive pressure ventilation. Patients who 
failed to improve with conservative intervention, were unable to be discharged from the hospital 
safely with conservative treatments, and underwent polysomnography demonstrating no central 
apnea and either an AHI > 20 or significant CO2 retention, are considered for mandibular 
distraction. All patients received a maxillofacial computed tomography scan with 3-D 
reconstructions to evaluate the quality of bone, mandibular morphology, position of the inferior 
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alveolar nerve, and presence of tooth buds.  Under the same anesthetic and prior to mandibular 
distraction, a pediatric otolaryngologist performed a direct laryngoscopy and rigid bronchoscopy.  
If other airway obstruction was observed, the treatment algorithm was altered appropriately at 
the discretion of the surgeon, and tracheotomy performed if indicated.  In the case of 
laryngomalacia, the protocol used was for a laser supraglottoplasty at that time if not 
contraindicated. All patients underwent mandibular distraction using either the micro Zurich or 
the Urata distractors (KLS Martin, Jacksonville, FL); with distraction started after a latency 
period of 2 to 5 days, activation at a rate of approximately 1mm/day and a consolidation of 
approximately 8 weeks.  The activation rate and vector were monitored with serial skull 
radiographs at weekly intervals. 
 
 
 
Statistical Analysis 
 Statistical analysis was performed using IBM SPSS for Windows, version 22 (IBM 
Corp., Armonk, NY). A student’s t-test was used to analyze parametric continuous variables, 
Mann-Whitney test for independent nonparametric continuous data, Wilcoxon signed-rank test 
for related nonparametric continuous data, and Fisher’s exact test was used to analyze dependent 
variable effects on the success or failure of MDO. Statistical significance was defined as p ≤ 
0.05. 
 
RESULTS 
One hundred twenty-one patients underwent MDO during the study period and 81 
patients met inclusion criteria.  The remaining 40 patients were ≥ 4 kg and used as a control 
group (Table 1).   Mean age and weight at time of distraction were 23 days old (range 5 to 97 
days) and 3.1 kg (range 2.00 to 3.99).  The mean age and weight for the control group was 2.7 
years (range 9 days to 14.6 years) and 11 kg (range 3.9 to 57.0 kg).  Prematurity (< 37 weeks of 
gestation), low birth weight (< 2500 g) and intrauterine growth restriction (IUGR)(< 10th 
percentile based on gestational age) were present in 25.0%, 30.0% and 31.3% of the patients < 4 
kg and 29.7%, 31.4% and 34.3% of the patients ≥ 4 kg (p =0.65, 1.00, and 0.83 respectively).  
Identifiable genetic syndrome was present in 34.2% of patients < 4 kg and 35.9% of patients ≥ 4 
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kg (p = 1.00).  The rates of significant neurologic, cardiac, gastrointestinal (non-GER), 
genitourinary, and other system anomalies were similar between those patients < 4 kg and ≥ 4 
kg:  21.3% vs 15.4%, p = 0.62; 23.8% vs. 15.0%, p = 0.34; 3.8% vs. 7.7%, p = 0.39; 12.5% vs 
5.1%, p = 0.33; and 30.0% vs. 20.5%, p = 0.38 respectively (Figure 1).  The rate of concomitant 
lower airway disease was 30.0% in patients < 4 kg and 53.8% in patients ≥ 4kg (p < 0.05), of 
which 79.2% and 81.0% were laryngomalacia respectively (p = 1.0).  Supraglottoplasty was 
performed in 56.3% of patients with laryngomalacia if < 4kg and 75.0% of patients ≥ 4 kg (p = 
0.46).   Gastroesophageal reflux (GER) was present in 38.8% of patients < 4kg and 46.2% of 
patients ≥ 4 kg (p = 0.55). Nissen fundoplication cited as an additional risk factor was performed 
in 10.1% of patients < 4 kg and 18.0% of patients ≥ 4 kg (p = 0.25).  Gastrostomy tube was 
present in 66.3% of patients < 4kg and 69.2% of patients ≥ 4kg (p = 0.84) (Figure 1).    
There was no significant difference in success of MDO to treat airway obstruction in the 
< 4 kg group vs. the control group (92.6% vs. 88.9%, p = 0.45) (Table 2).  Success was defined 
as either decannulation of tracheostomy, avoidance of tracheotomy, or significant improvement 
of obstructive sleep apnea symptoms allowing safe discharge home.  The mean pre-operative 
AHI was 41.5 vs. 26.1 in the control group (p < 0.008). The mean post-operative AHI was 12.1 
vs. 12.4 (p = 0.21) at 1 month and 5.8 vs. 3.1 (p = 0.90) at 1 year.  In patients < 4 kg and ≥ 4kg, 
AHI was significantly improved from preoperative values at 1 month (67.6% improvement, p < 
0.001 and 71.2% improvement, p < 0.001) and at 1 year (73.0% improvement, p < 0.02 and 
89.8% improvement, p < 0.005) (Figure 2). 
The number of patients < 4 kg with 1 or more complications (major, moderate, or minor 
including infectious) was 14 (17.3%) vs. 10 (25.0%) in the control group (p = 0.34) (Table 3).  
Within the < 4 kg group, major complications were present in 2 patients (2.5%), moderate 
complications in 6 patients (7.4%), and minor complications in 7 patients (8.6%) (Figure 3A).  A 
similar distribution of complications occurred in the control group: 0 major, 7 (17.5%) moderate, 
and 3 (7.5%) minor (p = 1.00, 0.12, and 1.00) (Figure 3B).  The only major complications in the 
patients < 4kg were fibrous non-union (1.2%) and severe trismus (1.2%) that did not respond to 
operative intervention. Moderate complications were device malfunction or dislodgement (3.7% 
in < 4kg and 5.0% in ≥ 4 kg, p = 1.00) and surgical site infection (SSI) requiring return to the 
operating room (4.9% in < 4 kg and 12.5% in ≥ 4 kg, p = 0.15).  Minor complications were SSI 
managed with oral antibiotics (4.9% in < 4 kg and 7.5 % in ≥ 4 kg, p = 0.68), ventilator-
AC
CE
P
ED
10 
 
associated pneumonia (1.2% in < 4 kg and 0 in ≥ 4 kg, p = 1.00), hematoma (1.2% in < 4 kg and 
0 in ≥ 4 kg, p = 1.00) and facial nerve neurapraxia (1.2% in < 4 kg and 0 in ≥ 4 kg, p = 1.00).  
The most common complication was SSI (9.9% of patients < 4 kg and 20.0% of patients ≥ 4 kg, 
p = 0.15), of which 50.0% and 35.3% were successfully treated by oral antibiotics alone.  There 
were no instances of TMJ ankyloses or permanent facial nerve palsies demonstrated in this 
series. 
The rates of repeat distraction were similar between the < 4 kg group and the control 
group (6.3% and 13.5%; p = 0.28).  The mean age at repeat distraction was 2.3 years in the < 4 
kg group and 9.2 years in the control group (p < 0.0001).  The mean follow up was 2.8 years 
(range 0.1 to 9.4 years) in patients < 4 kg and 3.0 years (range 0.1 to 10.1 years) in the control 
group (p = 0.68). 
 
DISCUSSION 
Mandibular Distraction Osteogenesis (MDO) has been demonstrated to be a safe3,11-17  
and effective3,6,8,12,13,15-17  intervention to relieve airway obstruction in infants with severe RS. 
Surgical outcomes in neonates during their first days of life however, have not been specifically 
studied. Due to concerns for performing jaw lengthening surgery at such an early age, some 
surgeons may opt to delay intervention until the newborn child grows and matures. 
Unfortunately, this delay in care may result in a prolonged period of intubation, longer NICU 
stay, temporary tracheostomy or an extended period of time in which the infant exists in a state 
of severe respiratory obstruction. Prolonged intubation increases risk to nosocomial pneumonia, 
tracheobronchial plugging, loss of airway, and increases the complexity of ICU care.  
 Tracheotomy has been associated with multiple complications including increased risk to 
tracheomalacia, chronic pneumonia, laryngeal stenosis, intellectual and physical impairments, 
compromised social interaction and requirement of complex nursing care and education.20-25 An 
extended ICU stay increases risk to nosocomial infection and increases the economic burden to 
the healthcare system. Alternatively, there can be significant risk associated with early MDO 
intervention in neonates during their first days of life. These children may be premature, 
underweight and may have multiple associated co-morbidities including intrauterine growth 
restriction (IUGR) and other organ system anomalies. In the background of these dichotomous 
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forces, the ideal time to intervene in neonates in their first days of life with RS and severe airway 
obstruction can be unclear. 
Early complications following MDO include surgical site infection, hematoma, device 
failure or dislodgement, neurapraxia, fibrous non-union, and fracture.11,18 Long-term 
complications include facial nerve injury, inferior alveolar nerve injury, tempormandibular joint 
(TMJ) ankylosis, trismus, injury to unerupted dentition, asymmetry, and disturbances of facial 
growth.  Most early complications can be managed effectively in the perioperative period with 
conservative therapy or early return to the operating room.  Long-term complications, although 
rare, can cause significant morbidity for the patient and are often referenced by centers opposed 
to early mandibular distraction.26-29 Further work with longer follow-up will be needed to 
delineate the long-term effects of distraction, although our series demonstrates promising results 
with nearly a decade of follow-up in some patients.       
We demonstrate that surgical outcomes of MDO in neonates with RS and severe airway 
obstruction are comparable to MDO applied to older and larger infants with RS.  The incidence 
of the majority of comorbidities was similar between the two groups. We chose <4 kg as our 
study population as surgical risk and complexity in other pediatric surgery specialties is 
associated with children who are low weight at the time of surgery, and the CPT code modifier 
uses the weight limit of 4 kg.30-32 One of the earliest reports by Denny on the use of MDO for the 
treatment of RS described 5 successfully treated patients who were under 4 kg at the time of 
surgery.5 There are several other reports on MDO for the treatment of RS, however these reports 
either describe a large patient population2 or make no specific mention of weight at the time of 
surgery.3,6,7,13,15  
Gastroesophageal reflux disease is a commonly associated condition with RS, and has 
been cited as a potential marker for more severe disease and worse outcomes.8, 15, 33-34   The 
etiology of GER in Robin sequence may be secondary to increased negative intrathoracic 
pressure, increased use of abdominal muscles, increased gastric pressure, the immaturity of the 
esophageal sphincter.  Untreated GER may lead to irreversible damage to the respiratory system. 
Monasterio et al demonstrate improvement in GER via esophageal pH monitoring on all patients 
prior to MDO and 4 months after intervention4.  The retrospective nature of the current study and 
lack of consistently employed objective monitoring techniques is a limitation of the current study 
for evaluating the effects of MDO on GER. 
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Other limitations of this study include the retrospective design and lack of long-term 
follow up. It is entirely possible that lower jaw surgery performed at the neonatal age is 
detrimental to future bony growth. Mandibular growth after MDO has not been fully studied and 
it is possible that mandibular distraction can cause iatrogenic damage to lower jaw growth. In 
addition, other complications associated with mandibular distraction could not be assessed by 
this relatively short-term follow up. These complications include: inferior alveolar nerve 
damage, iatrogenic damage to the deciduous and permanent teeth, TMJ ankylosis, effects on 
facial growth, and long-term scarring.  These patients will need to be followed until skeletal 
maturity to fully appreciate these effects.  Furthermore, this is a single institution experience 
which follows an institutionally derived algorithm and indications for MDO.   The concomitant 
treatment of laryngomalcia with supraglottoplasty adds a second intervention, and it is 
impossible to delineate the beneficial contribution of that intervention with the current 
retrospective study.   We suspect that supraglottoplasty in this case has only a minimal effect on 
overall outcome and could be performed at any time during the treatment algorithm, however 
further prospective or case-control studies will be needed.  Although our indications have been 
previously published,8,19 other distraction centers may have different indications, techniques and 
experience all of which can affect surgical outcome.  
It is important to stress that although the reported results suggest that MDO is safe to 
perform in infants less than 4 kg at the time of surgery, we do not recommend that MDO should 
be performed at this age at all centers. Neonatal as well as infant distraction should only be 
performed by experienced, high volume distraction centers with expert pediatric anesthesia and 
neonatal ICU care. Our recommendation for active distraction centers who are considering MDO 
in infants less than 4 kg is to progress to an earlier time of intervention with close collaboration 
with your pediatric anesthesia and neonatal ICU teams. The treacherous nature of MDO as 
applied to this very young subset of neonates cannot be more strongly emphasized. However, 
vigilant adherence to appropriate technique and airway control can result in an acceptably low 
complication profile as demonstrated in this report. Safety should be the first concern in guiding 
clinical decisions, therefore if the caring team is not experienced, prepared or comfortable with 
the timing of this type of intervention then surgery should be delayed and other treatment 
options, including tracheotomy should be considered. 
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CONCLUSIONS 
Mandibular distraction osteogenesis is a safe and effective treatment option for the 
treatment of severe Robin Sequence in infants weighing less than 4 kg. If the appropriate team 
and experience is available, the small or newborn status of the child should not delay the 
implementation of this treatment intervention. 
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Tables 
 
Table 1: Patients’ demographics 
 
  < 4kg ≥ 4kg p-values 
n 81 40 
Male/Female ratio 1.53 0.90 0.44  
Mean Age at MDO  23 ± 21 days 2.7 ± 3.7 years 
Mean Weight at MDO (kg) 3.1 ± 0.5 11 ± 12 
Prematurity 25.0% 29.7% 0.65  
Low Birth Weight 30.0% 31.4% 1.00  
IUGR 31.3% 34.3% 0.83 
Mean Length of Follow-up (years) 2.8 ± 2.3 3.0 ± 3.0 0.57  
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Table 2: Outcomes of infant Mandibular Distraction Osteogenesis 
 
  < 4 kg  ≥ 4 kg p-value 
Pre-op Tracheostomy 0.0% 25.0% <0.0001  
Post-op Tracheostomy 6.2% 11.1% 0.45  
Success 92.6% 88.9% 0.49 
Repeat 6.3% 13.5% 0.28  
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Table 3: Complications associated with infant Mandibular Distraction Osteogenesis 
 
  < 4kg  ≥ 4 kg  p-value 
All Complications 17.3% 25.0% 0.34  
     Major 2.5% 0.0% 1.00  
     Moderate 7.4% 17.5% 0.12  
     Minor 8.6% 7.5% 1.00  
Surgical Site Infections* 9.9% 20.0% 0.15  
Infections requiring I&D 4.9% 12.5% 0.15  
 
*Infectious complications included in all complications above 
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Figure 1. 
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Figure 2. 
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Figure 3. 
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